Inventor
VAN GOOL MICHIEL LUC MARIA
ES26 patents
⚠️ This page may combine multiple inventors who share the name “VAN GOOL MICHIEL LUC MARIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
18 patentsUS10005786B2Jun 26, 2018
Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of MGLUR2 receptors
JANSSEN PHARMACEUTICA NV3 citations71
US9550784B2Jan 24, 2017
Inhibitors of phosphodiesterase 10 enzyme
JANSSEN PHARMACEUTICA NV2 citations67
US11045562B2Jun 29, 2021
Radiolabelled mGluR2/3 PET ligands
JANSSEN PHARMACEUTICA NV0 citations58
US11033641B2Jun 15, 2021
Radiolabelled mGluR2/3 pet ligands
JANSSEN PHARMACEUTICA NV0 citations58
US10967078B2Apr 6, 2021
Radiolabelled mGluR2 PET ligands
JANSSEN PHARMACEUTICA NV0 citations56
US10512646B2Dec 24, 2019
Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors
JANSSEN PHARMACEUTICA NV0 citations50
US10112949B2Oct 30, 2018
6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptors
JANSSEN PHARMACEUTICA NV1 citations50
US9422296B2Aug 23, 2016
Fast-dissociating dopamine 2 receptor antagonists
JANSSEN PHARMACEUTICA NV0 citations50
US10668065B2Jun 2, 2020
6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptors
JANSSEN PHARMACEUTICA NV0 citations49
US10519162B2Dec 31, 2019
6,7-dihydropyrazolo[1,5-α]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptors
JANSSEN PHARMACEUTICA NV0 citations49
US10220032B2Mar 5, 2019
6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptors
JANSSEN PHARMACEUTICA NV0 citations49
US10005785B2Jun 26, 2018
Substituted 6,7-dihydropyrazolo[1,5-a] pyrazines as negative allosteric modulators of mGlUR2 receptors
JANSSEN PHARMACEUTICA NV1 citations49
US9828350B2Nov 28, 2017
5,6-dihydro-2H-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (BACE)
JANSSEN PHARMACEUTICA NV1 citations49
US10072014B2Sep 11, 2018
6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of MGLUR2 receptors
JANSSEN PHARMACEUTICA NV1 citations48
US10584129B2Mar 10, 2020
Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors
JANSSEN PHARMACEUTICA NV0 citations47
US10106524B2Oct 23, 2018
2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrol-5-amine compound inhibitors of beta-secretase
JANSSEN PHARMACEUTICA NV1 citations47
US10106542B2Oct 23, 2018
Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors
JANSSEN PHARMACEUTICA NV1 citations47
US10017514B2Jul 10, 2018
6,7-dihydropyrazolo[1,5-α]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptors
JANSSEN PHARMACEUTICA NV0 citations38
MACDONALD GREGOR JAMES
3 patentsUS8791120B2Jul 29, 2014
Fast-dissociating dopamine 2 receptor antagonists
MACDONALD GREGOR JAMES2 citations60
US8933101B2Jan 13, 2015
Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
MACDONALD GREGOR JAMES0 citations50
US8466153B2Jun 18, 2013
Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists
MACDONALD GREGOR JAMES0 citations50
BARTOLOMÉ-NEBREDA JOSÉ MANUEL
2 patentsUS8859543B2Oct 14, 2014
Imidazo[1,2-a]pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases
BARTOLOMÉ-NEBREDA JOSÉ MANUEL3 citations56
US8895562B2Nov 25, 2014
Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists
BARTOLOMÉ-NEBREDA JOSÉ MANUEL0 citations47